QuantumPharm Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,314	710.76	574.22	3,524
Short-Term Investments	417.02	1,263	2,552	314.09
Trading Asset Securities	1,655	863.37	356.36	-
Cash & Short-Term Investments	3,386	2,838	3,483	3,838
Cash Growth	-11.77%	-18.52%	-9.26%	-
Accounts Receivable	58.53	38.51	37.94	30.72
Other Receivables	13	19.76	22.95	16.26
Receivables	76.53	58.26	60.89	46.98
Prepaid Expenses	-	9.3	14.53	5.04
Restricted Cash	0.53	2.34	5.43	12.75
Other Current Assets	47.03	37.89	33.28	17.05
Total Current Assets	3,510	2,945	3,597	3,920
Property, Plant & Equipment	452.37	559.14	395.63	270.57
Long-Term Investments	480.55	468.42	303.24	170.47
Other Intangible Assets	7.85	7.87	6.68	5.12
Other Long-Term Assets	11.72	24.92	13.89	16.05
Total Assets	4,463	4,006	4,316	4,382
Accounts Payable	7.7	13.65	13.98	10.57
Accrued Expenses	49.56	74.11	69.91	48.65
Short-Term Debt	64.9	60	36	-
Current Portion of Long-Term Debt	-	-	-	22.28
Current Portion of Leases	23.25	58.78	24.25	17.3
Current Income Taxes Payable	2.17	4.27	4.48	2.49
Current Unearned Revenue	32.21	33.09	16.64	11.83
Other Current Liabilities	44.09	53.47	32.39	47.75
Total Current Liabilities	223.87	297.38	197.65	160.87
Long-Term Debt	-	10,780	9,321	7,712
Long-Term Leases	75.42	137.18	69.21	81.67
Long-Term Unearned Revenue	21.78	32.04	29.63	30.64
Other Long-Term Liabilities	-	-	8.64	0.28
Total Liabilities	321.07	11,247	9,626	7,986
Common Stock	0.24	0.05	0.05	0.05
Additional Paid-In Capital	12,588	4.59	4.59	4.59
Retained Earnings	-8,293	-7,040	-5,126	-3,684
Treasury Stock	-0.02	-0.02	-0.02	-0.02
Comprehensive Income & Other	-179.93	-231.68	-206.33	70.05
Total Common Equity	4,116	-7,267	-5,328	-3,609
Minority Interest	25.85	26.17	17.88	5.39
Shareholders' Equity	4,142	-7,241	-5,310	-3,604
Total Liabilities & Equity	4,463	4,006	4,316	4,382
Total Debt	163.57	11,036	9,450	7,834
Net Cash (Debt)	3,222	-8,199	-5,968	-3,996
Net Cash Per Share	5.31	-16.94	-12.33	-8.29
Filing Date Shares Outstanding	729.15	782.02	483.98	482.27
Total Common Shares Outstanding	729.15	782.02	483.98	482.27
Working Capital	3,286	2,648	3,399	3,759
Book Value Per Share	5.64	-9.29	-11.01	-7.48
Tangible Book Value	4,108	-7,275	-5,334	-3,614
Tangible Book Value Per Share	5.63	-9.30	-11.02	-7.49
Machinery	-	261.38	182.56	73.24
Construction In Progress	-	98.1	120.88	52.18
Leasehold Improvements	-	141.86	77.54	69.6

Source: S&P Capital IQ. Standard template. Financial Sources.